The Role of Resveratrol in Aging and Senescence: A Focus on
Molecular Mechanisms

Zeynab      Kohandel; Majid      Darrudi; Kobra      Naseri; Fariborz      Samini; Michael      Aschner; Ali   Mohammad   Pourbagher-Shahri; Saeed      Samarghandian
doi:10.2174/1566524023666230602162949
Abstract

Resveratrol (Res), a polyphenol found in red wine, has been shown to decelerate aging, the progressive loss of physiological integrity and cellular senescence, characterized by the inability to progress through the cell cycle. No successful clinical trials have yet to be completed in humans on dose limitations. Yet, the potent anti-aging and anti-senescence efficacy of Res has been documented in several in vivo animal models. In this review, we highlight the molecular mechanisms of Res efficacy in antiaging disorders, such as diabetes, neurodegenerative disorders, eye diseases, and cardiovascular diseases.
Keywords: Resveratrol, aging, senescence, molecular mechanisms, oxidative stress, inflammation.
« Previous Next »
[1]
Di Micco R, Krizhanovsky V, Baker D, d’Adda di Fagagna F. Cellular senescence in ageing: From mechanisms to therapeutic opportunities. Nat Rev Mol Cell Biol  2021; 22(2): 75-95.
 [http://dx.doi.org/10.1038/s41580-020-00314-w] [PMID: 33328614]

[2]
Schmeer C, Kretz A, Wengerodt D, Stojiljkovic M, Witte OW. Dissecting aging and senescence-current concepts and open lessons. Cells  2019; 8(11): 1446.
 [http://dx.doi.org/10.3390/cells8111446] [PMID: 31731770]

[3]
McHugh D, Gil J. Senescence and aging: Causes, consequences, and therapeutic avenues. J Cell Biol  2018; 217(1): 65-77.
 [http://dx.doi.org/10.1083/jcb.201708092] [PMID: 29114066]

[4]
Hoenicke L, Zender L. Immune surveillance of senescent cells-biological significance in cancer- and non-cancer pathologies. Carcinogenesis  2012; 33(6): 1123-6.
 [http://dx.doi.org/10.1093/carcin/bgs124] [PMID: 22470164]

[5]
López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell  2013; 153(6): 1194-217.
 [http://dx.doi.org/10.1016/j.cell.2013.05.039] [PMID: 23746838]

[6]
Campisi J, d’Adda di Fagagna F. Cellular senescence: When bad things happen to good cells. Nat Rev Mol Cell Biol  2007; 8(9): 729-40.
 [http://dx.doi.org/10.1038/nrm2233] [PMID: 17667954]

[7]
Campisi J. Aging, cellular senescence, and cancer. Annu Rev Physiol  2013; 75(1): 685-705.
 [http://dx.doi.org/10.1146/annurev-physiol-030212-183653] [PMID: 23140366]

[8]
Campisi J, Andersen JK, Kapahi P, Melov S. Cellular senescence: A link between cancer and age-related degenerative disease? Semin Cancer Biol  2011; 21(6): 354-9.
 [http://dx.doi.org/10.1016/j.semcancer.2011.09.001] [PMID: 21925603]

[9]
Rodier F, Campisi J. Four faces of cellular senescence. J Cell Biol  2011; 192(4): 547-56.
 [http://dx.doi.org/10.1083/jcb.201009094] [PMID: 21321098]

[10]
Acosta JC, O’Loghlen A, Banito A, et al. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell  2008; 133(6): 1006-18.
 [http://dx.doi.org/10.1016/j.cell.2008.03.038] [PMID: 18555777]

[11]
Burton DGA, Krizhanovsky V. Physiological and pathological consequences of cellular senescence. Cell Mol Life Sci  2014; 71(22): 4373-86.
 [http://dx.doi.org/10.1007/s00018-014-1691-3] [PMID: 25080110]

[12]
Campisi J. Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol  2001; 11(11): S27-31.
 [http://dx.doi.org/10.1016/S0962-8924(01)02151-1] [PMID: 11684439]

[13]
Dimri GP. What has senescence got to do with cancer? Cancer Cell  2005; 7(6): 505-12.
 [http://dx.doi.org/10.1016/j.ccr.2005.05.025] [PMID: 15950900]

[14]
Gewirtz DA, Holt SE, Elmore LW. Accelerated senescence: An emerging role in tumor cell response to chemotherapy and radiation. Biochem Pharmacol  2008; 76(8): 947-57.
 [http://dx.doi.org/10.1016/j.bcp.2008.06.024] [PMID: 18657518]

[15]
Ewald JA, Desotelle JA, Wilding G, Jarrard DF. Therapy-induced senescence in cancer. J Natl Cancer Inst  2010; 102(20): 1536-46.
 [http://dx.doi.org/10.1093/jnci/djq364] [PMID: 20858887]

[16]
Schmitt CA, Fridman JS, Yang M, et al. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell  2002; 109(3): 335-46.
 [http://dx.doi.org/10.1016/S0092-8674(02)00734-1] [PMID: 12015983]

[17]
Amiri F, Zarnani AH, Zand H, Koohdani F, Jeddi-Tehrani M, Vafa M. Synergistic anti-proliferative effect of resveratrol and etoposide on human hepatocellular and colon cancer cell lines. Eur J Pharmacol  2013; 718(1-3): 34-40.
 [http://dx.doi.org/10.1016/j.ejphar.2013.09.020] [PMID: 24055188]

[18]
Gao Z, Xu MS, Barnett TL, Xu CW. Resveratrol induces cellular senescence with attenuated mono-ubiquitination of histone H2B in glioma cells. Biochem Biophys Res Commun  2011; 407(2): 271-6.
 [http://dx.doi.org/10.1016/j.bbrc.2011.02.008] [PMID: 21481687]

[19]
Samarghandian S, Azimi-Nezhad M, Mehrad-Majd H, Mirhafez SR. Thymoquinone ameliorates acute renal failure in gentamicin-treated adult male rats. Pharmacology  2015; 96(3-4): 112-7.
 [http://dx.doi.org/10.1159/000436975] [PMID: 26202209]

[20]
Harikumar KB, Aggarwal BB. Resveratrol: A multitargeted agent for age-associated chronic diseases. Cell Cycle  2008; 7(8): 1020-35.
 [http://dx.doi.org/10.4161/cc.7.8.5740] [PMID: 18414053]

[21]
Ghorbani A, Zand H, Jeddi-Tehrani M, Koohdani F, Shidfar F, Keshavarz SA. PTEN over-expression by resveratrol in acute lymphoblastic leukemia cells along with suppression of AKT/PKB and ERK1/2 in genotoxic stress. J Nat Med  2015; 69(4): 507-12.
 [http://dx.doi.org/10.1007/s11418-015-0915-7] [PMID: 25929783]

[22]
Saiko P, Szakmary A, Jaeger W, Szekeres T. Resveratrol and its analogs: Defense against cancer, coronary disease and neurodegenerative maladies or just a fad? Mutat Res Rev Mutat Res  2008; 658(1-2): 68-94.
 [http://dx.doi.org/10.1016/j.mrrev.2007.08.004] [PMID: 17890139]

[23]
Li B, Hou D, Guo H, et al. Resveratrol sequentially induces replication and oxidative stresses to drive p53-CXCR2 mediated cellular senescence in cancer cells. Sci Rep  2017; 7(1): 208.
 [http://dx.doi.org/10.1038/s41598-017-00315-4] [PMID: 28303009]

[24]
Bishayee A, Dhir N. Resveratrol-mediated chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis: Inhibition of cell proliferation and induction of apoptosis. Chem Biol Interact  2009; 179(2-3): 131-44.
 [http://dx.doi.org/10.1016/j.cbi.2008.11.015] [PMID: 19073162]

[25]
Athar M, Back J, Tang X, et al. Resveratrol: A review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol  2007; 224(3): 274-83.
 [http://dx.doi.org/10.1016/j.taap.2006.12.025] [PMID: 17306316]

[26]
Wang W, Li P, Xu J, et al. Resveratrol attenuates high glucose-induced nucleus pulposus cell apoptosis and senescence through activating the ROS-mediated PI3K/Akt pathway. Biosci Rep  2018; 38(2): BSR20171454.
 [http://dx.doi.org/10.1042/BSR20171454] [PMID: 29273676]

[27]
Tang Y, Xu J, Qu W, et al. Resveratrol reduces vascular cell senescence through attenuation of oxidative stress by SIRT1/NADPH oxidase-dependent mechanisms. J Nutr Biochem  2012; 23(11): 1410-6.
 [http://dx.doi.org/10.1016/j.jnutbio.2011.08.008] [PMID: 22284404]

[28]
Zhang E, Guo Q, Gao H, Xu R, Teng S, Wu Y. Metformin and resveratrol inhibited high glucose-induced metabolic memory of endothelial senescence through SIRT1/p300/p53/p21 pathway. PLoS One  2015; 10(12): e0143814.
 [http://dx.doi.org/10.1371/journal.pone.0143814] [PMID: 26629991]

[29]
Yang Q, Wang B, Zang W, et al. Resveratrol inhibits the growth of gastric cancer by inducing G1 phase arrest and senescence in a Sirt1-dependent manner. PLoS One  2013; 8(11): e70627.
 [http://dx.doi.org/10.1371/journal.pone.0070627] [PMID: 24278101]

[30]
Luo H, Yang A, Schulte BA, Wargovich MJ, Wang GY. Resveratrol induces premature senescence in lung cancer cells via ROS-mediated DNA damage. PLoS One  2013; 8(3): e60065.
 [http://dx.doi.org/10.1371/journal.pone.0060065] [PMID: 23533664]

[31]
Howitz KT, Bitterman KJ, Cohen HY, et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature  2003; 425(6954): 191-6.
 [http://dx.doi.org/10.1038/nature01960] [PMID: 12939617]

[32]
Wood JG, Rogina B, Lavu S, et al. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature  2004; 430(7000): 686-9.
 [http://dx.doi.org/10.1038/nature02789] [PMID: 15254550]

[33]
Valenzano DR, Terzibasi E, Genade T, Cattaneo A, Domenici L, Cellerino A. Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate. Curr Biol  2006; 16(3): 296-300.
 [http://dx.doi.org/10.1016/j.cub.2005.12.038] [PMID: 16461283]

[34]
Kilic Eren M, Kilincli A, Eren Ö. Resveratrol induced premature senescence is associated with DNA damage mediated SIRT1 and SIRT2 down-regulation. PLoS One  2015; 10(4): e0124837.
 [http://dx.doi.org/10.1371/journal.pone.0124837] [PMID: 25924011]

[35]
Li T, Peng F, Reiter RJ, Yang Y. Editorial: SIRT family in endocrinology. Front Endocrinol  2019; 10: 347.
 [http://dx.doi.org/10.3389/fendo.2019.00347] [PMID: 31214121]

[36]
Vassilopoulos A, Fritz KS, Petersen DR, Gius D. The human sirtuin family: Evolutionary divergences and functions. Hum Genomics  2011; 5(5): 485-96.
 [http://dx.doi.org/10.1186/1479-7364-5-5-485] [PMID: 21807603]

[37]
Giovannelli L, Pitozzi V, Jacomelli M, et al. Protective effects of resveratrol against senescence-associated changes in cultured human fibroblasts. J Gerontol A Biol Sci Med Sci  2011; 66A(1): 9-18.
 [http://dx.doi.org/10.1093/gerona/glq161] [PMID: 20884849]

[38]
Zang M, Xu S, Maitland-Toolan KA, et al. Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes  2006; 55(8): 2180-91.
 [http://dx.doi.org/10.2337/db05-1188] [PMID: 16873680]

[39]
Baur JA, Pearson KJ, Price NL, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature  2006; 444(7117): 337-42.
 [http://dx.doi.org/10.1038/nature05354] [PMID: 17086191]

[40]
Reinisalo M, Kårlund A, Koskela A, Kaarniranta K, Karjalainen RO. Polyphenol stilbenes: Molecular mechanisms of defence against oxidative stress and aging-related diseases. Oxid Med Cell Longev  2015; 2015: 1-24.
 [http://dx.doi.org/10.1155/2015/340520] [PMID: 26180583]

[41]
Taguchi K, Fujikawa N, Komatsu M, et al. Keap1 degradation by autophagy for the maintenance of redox homeostasis. Proc Natl Acad Sci USA  2012; 109(34): 13561-6.
 [http://dx.doi.org/10.1073/pnas.1121572109] [PMID: 22872865]

[42]
Liu X, Peyton KJ, Shebib AR, Wang H, Korthuis RJ, Durante W. Activation of AMPK stimulates heme oxygenase-1 gene expression and human endothelial cell survival. Am J Physiol Heart Circ Physiol  2011; 300(1): H84-93.
 [http://dx.doi.org/10.1152/ajpheart.00749.2010] [PMID: 21037234]

[43]
Kornicka K, Szłapka-Kosarzewska J, Śmieszek A, Marycz K. 5-Azacytydine and resveratrol reverse senescence and ageing of adipose stem cells via modulation of mitochondrial dynamics and autophagy. J Cell Mol Med  2019; 23(1): 237-59.
 [http://dx.doi.org/10.1111/jcmm.13914] [PMID: 30370650]

[44]
Matos L, Gouveia AM, Almeida H. Resveratrol attenuates copper-induced senescence by improving cellular proteostasis. Oxid Med Cell Longev  2017; 2017: 1-12.
 [http://dx.doi.org/10.1155/2017/3793817] [PMID: 28280523]

[45]
Siemann EH, Creasy LL. Concentration of the phytoalexin resveratrol in wine. Am J Enol Vitic  1992; 43(1): 49-52.
 [http://dx.doi.org/10.5344/ajev.1992.43.1.49]

[46]
Hattori R, Otani H, Maulik N, Das DK. Pharmacological preconditioning with resveratrol: Role of nitric oxide. Am J Physiol Heart Circ Physiol  2002; 282(6): H1988-95.
 [http://dx.doi.org/10.1152/ajpheart.01012.2001] [PMID: 12003802]

[47]
Farkhondeh T, Llorens S, Pourbagher-Shahri AM, et al. An overview of the role of adipokines in cardiometabolic diseases. Molecules  2020; 25(21): 5218.
 [http://dx.doi.org/10.3390/molecules25215218 ] [PMID: 33182462]

[48]
Bonnefont-Rousselot D. Resveratrol and cardiovascular diseases. Nutrients  2016; 8(5): 250.
 [http://dx.doi.org/10.3390/nu8050250] [PMID: 27144581]

[49]
Dehghani A, Hafizibarjin Z, Najjari R, Kaseb F, Safari F. Resveratrol and 1,25-dihydroxyvitamin D co-administration protects the heart against d-galactose-induced aging in rats: Evaluation of serum and cardiac levels of klotho. Aging Clin Exp Res  2019; 31(9): 1195-205.
 [http://dx.doi.org/10.1007/s40520-018-1075-x] [PMID: 30484255]

[50]
Shaterzadeh-Yazdi H, Noorbakhsh MF, Hayati F, Samarghandian S, Farkhondeh T. Immunomodulatory and anti-inflammatory effects of thymoquinone. Cardiovascular & Haematological Disorders-Drug Targets (Formerly Current Drug Targets-Cardiovascular & Hematological Disorders)  2018; 18(1): 52-60.
 [http://dx.doi.org/10.1016/j.intimp.2015.06.023] [PMID: 26117430]

[51]
Börzsei D, Sebestyén J, Szabó R, et al. Resveratrol as a promising polyphenol in age-associated cardiac alterations. Oxid Med Cell Longev  2022; 2022: 1-8.
 [http://dx.doi.org/10.1155/2022/7911222] [PMID: 35761875]

[52]
Chu SH, Yang D, Wang Y, Yang R, Qu L, Zeng H. Effect of resveratrol on the repair of kidney and brain injuries and its regulation on klotho gene in d-galactose-induced aging mice. Bioorg Med Chem Lett  2021; 40: 127913.
 [http://dx.doi.org/10.1016/j.bmcl.2021.127913] [PMID: 33705905]

[53]
Sovrani V, Bobermin LD, Santos CL, et al. Effects of long-term resveratrol treatment in hypothalamic astrocyte cultures from aged rats. Mol Cell Biochem  2022; 2022: 8638714.
 [http://dx.doi.org/10.1007/s11010-022-04585-z] [PMID: 36272012]

[54]
Amirazodi M, Daryanoosh F, Mehrabi A, et al. Interactive effects of swimming high-intensity interval training and resveratrol supplementation improve mitochondrial protein levels in the hippocampus of aged rats. BioMed Res Int  2022; 2022: 1-10.
 [http://dx.doi.org/10.1155/2022/8638714] [PMID: 36536955]

[55]
Uddin MJ, Farjana M, Moni A, Hossain KS, Hannan MA, Ha H. Prospective pharmacological potential of resveratrol in delaying kidney aging. Int J Mol Sci  2021; 22(15): 8258.
 [http://dx.doi.org/10.3390/ijms22158258] [PMID: 34361023]

[56]
Kim EN, Lim JH, Kim MY, et al. Resveratrol, an Nrf2 activator, ameliorates aging-related progressive renal injury. Aging  (Albany NY)  2018; 10(1): 83-99.
 [http://dx.doi.org/10.18632/aging.101361] [PMID: 29326403]

[57]
Abharzanjani F, Hemmati M. Protective effects of Quercetin and Resveratrol on aging markers in kidney under high glucose condition: In vivo and in vitro analysis. Mol Biol Rep  2021; 48(7): 5435-42.
 [http://dx.doi.org/10.1007/s11033-021-06550-3] [PMID: 34273031]

[58]
Jang IA, Kim E, Lim J, et al. Effects of resveratrol on the renin-angiotensin system in the aging kidney. Nutrients  2018; 10(11): 1741.
 [http://dx.doi.org/10.3390/nu10111741] [PMID: 30424556]

[59]
Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA. Future of cancer incidence in the United States: Burdens upon an aging, changing nation. J Clin Oncol  2009; 27(17): 2758-65.
 [http://dx.doi.org/10.1200/JCO.2008.20.8983] [PMID: 19403886]

[60]
Faget DV, Ren Q, Stewart SA. Unmasking senescence: Context-dependent effects of SASP in cancer. Nat Rev Cancer  2019; 19(8): 439-53.
 [http://dx.doi.org/10.1038/s41568-019-0156-2] [PMID: 31235879]

[61]
Samarghandian S, Azimi-Nezhad M, Samini F. Preventive effect of safranal against oxidative damage in aged male rat brain. Experimental Animals  2015; 64(1): 65-71.
 [http://dx.doi.org/10.1538/expanim.14-0027] [PMID: 25312506]

[62]
Wang L, Ebrahimi KB, Chyn M, Cano M, Handa JT. Biology of p62/sequestosome-1 in Age-Related Macular Degeneration (AMD). Adv Exp Med Biol  2016; 854: 17-22.
 [http://dx.doi.org/10.1007/978-3-319-17121-0_3]

[63]
Kelly GS. A review of the sirtuin system, its clinical implications, and the potential role of dietary activators like resveratrol: Part 2. Altern Med Rev  2010; 15(4): 313-28.

[64]
Kolosova NG, Kozhevnikova OS, Telegina DV, et al. p62/SQSTM1 coding plasmid prevents age related macular degeneration in a rat model. Aging   2018; 10(8): 2136-47.
 [http://dx.doi.org/10.18632/aging.101537] [PMID: 30153656]

[65]
Oyenihi OR, Oyenihi AB, Adeyanju AA, Oguntibeju OO. Antidiabetic effects of resveratrol: The way forward in its clinical utility. J Diabetes Res  2016; 2016: 1-14.
 [http://dx.doi.org/10.1155/2016/9737483] [PMID: 28050570]

[66]
Scrocchi LA, Drucker DJ. Effects of aging and a high fat diet on body weight and glucose tolerance in glucagon-like peptide-1 receptor -/- mice. Endocrinology  1998; 139(7): 3127-32.
 [http://dx.doi.org/10.1210/endo.139.7.6092] [PMID: 9645685]

[67]
Thadhani VM. Resveratrol in management of diabetes and obesity: Clinical applications, bioavailability, and nanotherapyResveratrol. United Kingdom: IntechOpen 2019.
 [http://dx.doi.org/10.5772/intechopen.79498]

[68]
Jeyaraman MM, Al-Yousif NSH, Singh Mann A, et al. Resveratrol for adults with type 2 diabetes mellitus. Cochrane Libr  2020; 2020(1): CD011919.
 [http://dx.doi.org/10.1002/14651858.CD011919.pub2] [PMID: 31978258]
Rights & Permissions Print Cite
Article Metrics
51
2
Journal Information
For Authors
For Editors
For Reviewers
Explore Articles
Open Access
Open Access Articles
For Visitors
DOI https://dx.doi.org/10.2174/1566524023666230602162949	Print ISSN 1566-5240
Publisher Name Bentham Science Publisher	Online ISSN 1875-5666
Current Molecular Medicine

The Role of Resveratrol in Aging and Senescence: A Focus on Molecular Mechanisms

Abstract

Molecular and Cellular Mechanisms in Vertigo / Vestibular Disorders

Current Molecular Medicine

The Role of Resveratrol in Aging and Senescence: A Focus on Molecular Mechanisms

Abstract

Call for Papers in Thematic Issues

Molecular and Cellular Mechanisms in Vertigo / Vestibular Disorders

Related Journals

Related Books

Related Articles
